Apimeds Pharmaceuticals US, Inc. (APUS) stock
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.89−0.06 (-3.08%)
Close on Nov 18, 2026Market cap $2.85MP/E –Yield –
Apimeds Pharmaceuticals US gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.84M | – |
See a number that looks wrong?